Who We Are

Cytovation builds on over 15 years of cutting-edge research from two leading Norwegian institutions; University of Bergen and Haukeland University Hospital. Led by a highly experienced management team and world-renowned experts in tumour biology, an extensive research program has focused on engineering synthetic peptides with unique properties. CyPep-1, the company’s lead candidate, is being developed as a first-in-class lytic agent for the treatment of solid tumors.

Management Team

Lars Prestegarden MD, PhD

Chief Executive Officer

Associate professor of medicine with more than 15 years experience in cancer research.

Kjell-Inge Arnevig

Chief Operating Officer

Serial entrepreneur with over 25 years of experience as managing director in global industrial enterprises.

Federico Grego

Chief Business Officer

20+ yrs of senior general management experience in specialty pharma (immunology & dermatology).

Raj Airey


25+ years experience in the pharma sector. Senior management roles in Pfizer and Baxter.

Jeanette Kamman

Project manager

25+ years of experience in phase I-IV trials in the clinical research industry in various positions, with recent years in oncology research.

Ole-Erik Iversen, MD, PhD

Scientific Advisor

Professor Emeritus and University of Bergen. International KOL Cervical Cancer. Principal investigator HPV vaccines.

Xavier Luria, MD

Regulatory Advisor

Founder and CEO Drug Development & Regulation (DDR). Former Head of Safety and Efficacy of Medicines, European Medicines Agency.

Board of Directors

Per Eystein Lønning, MD, PhD

Chairman & Founder

Professor of Oncology University of Bergen. Over 35 years of research experience with 300+ Publications.

Rolf Bjerkvig, PhD

Board Member & Founder

Professor of Cancer Biology University of Bergen. Director of Oncology in Luxembourg.

Stein Christian Mohn, MD, PhD

Board Member

Medical doctor with 15 years of senior executive management experience.

Egil Herman Sjursen

Board Member

Experienced in finance and executive management. Executive board member Central bank of Norway. Previously CEO at Vesta, Nordea and Holberg.